Translational Lung Cancer Research is a peer-reviewed english-language open-access journal published by AME Publishing Company in Hong Kong, operating under an open-access model since 2012. The journal covers Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens.
Authors are required to pay an article processing charge to publish in Translational Lung Cancer Research; refer to the journal's APC page for the current rate. A waiver policy is offered for eligible authors. Articles are released under the CC BY-NC-ND license (see other journals using this license).
All submissions undergo plagiarism screening before peer review.
Keywords
lung cancer, thoracic oncology, oncology
At a glance
- Publisher
- AME Publishing Company
- Country
- Hong Kong
- Primary language
- English
- License
- CC BY-NC-ND
- Peer review
- Double anonymous peer review
- OA since
- 2012
- Review time
- 17 weeks
- Plagiarism check
- Yes
ISSN
- 2218-6751
- electronic
- 2226-4477
Frequently asked questions
Is Translational Lung Cancer Research peer-reviewed?
Does Translational Lung Cancer Research charge an article processing charge (APC)?
What subjects does Translational Lung Cancer Research publish?
What languages does Translational Lung Cancer Research accept?
What is the ISSN of Translational Lung Cancer Research?
2218-6751 (print) · 2226-4477 (electronic).